Taking advantage of the CD19-driven S1P1 deletion mouse model, we determined that HP could be fully induced in absence of massive B cell accumulation in the lung, arguing against the theory that interventions aimed at reducing B cells locally in the lung may interfere with HP development. The gene discussed is S1PR1; the disease is hypersensitivity pneumonitis.